| Date Filed | Doc # | Docket Text |
|
| 2023-04-10 | 1 | COMPLAINT against FOOD AND DRUG ADMINISTRATION ( Filing fee $ 402 receipt number AMDDC-10534825.), filed by EXELA PHARMA SCIENCES, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Civil Cover Sheet Civil Cover Sheet, # 23 Summons Summons, # 24 Summons Summons, # 25 Summons Summons)(Lienhard, Jonathan) (Entered: 04/10/2023) |
| 2023-04-10 | 2 | [FILED IN ERROR] Local Rule 103.3 Disclosure Statement by Exela Pharma Sciences, LLC (Lienhard, Jonathan) Modified on 4/11/2023 (mg3s, Deputy Clerk). (Entered: 04/10/2023) |
| 2023-04-11 | 3 | Summons Issued 30 days as to Food and Drug Administration, U.S. Attorney and U.S. Attorney General(mg3s, Deputy Clerk) Modified on 5/5/2023 (mg3s, Deputy Clerk). (Entered: 04/11/2023) |
| 2023-04-11 | 4 | QC NOTICE: 2 Local Rule 103.3 Disclosure Statement filed by Exela Pharma Sciences, LLC was filed incorrectly. **Please refile the Local Rule 103.3 Disclosure Statement. Everyone designated on your disclosure statement as having financial interest in the outcome of the case needs to be added as a corporate parent or other affiliate when the system prompts you. It has been noted as FILED IN ERROR, and the document link has been disabled. (mg3s, Deputy Clerk). (Entered: 04/11/2023) |
| 2023-04-11 | 5 | Local Rule 103.3 Disclosure Statement by Exela Pharma Sciences, LLC identifying Corporate Parent Exela Pharm Sci, Inc., Other Affiliate Exela Holdings, Inc. for Exela Pharma Sciences, LLC.(Lienhard, Jonathan) (Entered: 04/11/2023) |
| 2023-04-19 | 6 | MOTION to Appear Pro Hac Vice for Jason Torchinsky (Filing fee $100, receipt number AMDDC-10551981.) by Exela Pharma Sciences, LLC (Attachments: # 1 Rider A - List of Court Admissions)(Lienhard, Jonathan) (Entered: 04/19/2023) |
| 2023-04-19 | 7 | MOTION to Appear Pro Hac Vice for Edward M. Wenger (Filing fee $100, receipt number AMDDC-10552048.) by Exela Pharma Sciences, LLC (Attachments: # 1 Rider A - List of Court Admissions)(Lienhard, Jonathan) (Entered: 04/19/2023) |
| 2023-04-19 | 8 | PAPERLESS ORDER granting 6 Motion to Appear Pro Hac Vice on behalf of Jason Brett Torchinsky. Directing attorney Jason Brett Torchinsky to register for pro hac vice filing in the District of Maryland through PACER at https://pacer.uscourts.gov/ if attorney has not already done so. The Pro Hac Vice option must be selected when registering. Signed by Clerk on 4/19/2023. (mh4s, Deputy Clerk) (Entered: 04/19/2023) |
| 2023-04-19 | 9 | PAPERLESS ORDER granting 7 Motion to Appear Pro Hac Vice on behalf of Edward Wenger. Directing attorney Edward Wenger to register for pro hac vice filing in the District of Maryland through PACER at https://pacer.uscourts.gov/ if attorney has not already done so. The Pro Hac Vice option must be selected when registering. Signed by Clerk on 4/19/2023. (mh4s, Deputy Clerk) (Entered: 04/19/2023) |
| 2023-04-25 | 10 | SUMMONS Returned Executed by Exela Pharma Sciences, LLC. Food and Drug Administration served on 4/11/2023, answer due 5/11/2023. (Attachments: # 1 Exhibit A)(Lienhard, Jonathan) Modified on 5/5/2023 (mg3s, Deputy Clerk). (Entered: 04/25/2023) |
| 2023-05-26 | 11 | ANSWER to 1 Complaint,, by Food and Drug Administration.(Wilson, Michael) (Entered: 05/26/2023) |
| 2023-06-20 | 12 | SCHEDULING ORDER: Status Report due by 11/2/2023. Signed by Judge Paula Xinis on 6/20/2023. (mg3s, Deputy Clerk). (Entered: 06/21/2023) |
| 2023-06-20 | 13 | LETTER ORDER regarding the Filing of Discovery Motions. Signed by Judge Paula Xinis on 6/20/2023. (mg3s, Deputy Clerk). (Entered: 06/21/2023) |
| 2023-07-05 | 14 | STATUS REPORT (Joint) by Food and Drug Administration(Wilson, Michael) (Entered: 07/05/2023) |
| 2023-07-06 | 15 | PAPERLESS NOTICE: The Rule 16 conference call set for July 7, 2023 has been RESCHEDULED to July 14, 2023 at 10:15 a.m. Plaintiff should initiate call to Chambers, (301) 344-0653. (tb2s, Chambers) (Entered: 07/06/2023) |
| 2023-07-12 | 16 | PAPERLESS ORDER: The Rule 16 conference call scheduled for July 14, 2023 is CANCELLED. Parties should submit a Joint Status Report by August 9, 2023. Signed by Judge Paula Xinis on 7/12/2023. (tb2s, Chambers) (Entered: 07/12/2023) |
| 2023-08-09 | 17 | STATUS REPORT (Joint) by Food and Drug Administration(Wilson, Michael) (Entered: 08/09/2023) |
| 2023-08-10 | 18 | PAPERLESS ORDER STRIKING 12 Scheduling Order. Parties are DIRECTED to file Joint Status Report no later than February 9, 2024. Signed by Judge Paula Xinis on 8/10/2023. (dg3s, Deputy Clerk) (Entered: 08/10/2023) |
| 2024-02-09 | 19 | STATUS REPORT (Joint) by Food and Drug Administration(Wilson, Michael) (Entered: 02/09/2024) |
| 2024-02-13 | 20 | PAPERLESS ORDER staying the case for 60 days and directing parties to file a joint status report by no later than April 9, 2024. Signed by Judge Paula Xinis on 2/13/2024. (mg3s, Deputy Clerk) (Entered: 02/13/2024) |
 Hide Docket Events |
|
